Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: An image auditing method and system may be provided. Video surveillance equipment may be operated in coordination with at least one digital computer across network architecture. The video surveillance equipment may provide a computer with footage of a transactions occurring in a target area. The footage may be filtered into at least one image of a transaction. The image may be categorized based on at least one transaction characteristic. The transaction data may be compared to transaction records from a point of sale and analyzed for any discrepancies.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: An image auditing method and system may be provided. Video surveillance equipment may be operated in coordination with at least one digital computer across network architecture. The video surveillance equipment may provide a computer with footage of a transactions occurring in a target area. The footage may be filtered into at least one image of a transaction. The image may be categorized based on at least one transaction characteristic. The transaction data may be compared to transaction records from a point of sale and analyzed for any discrepancies.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: An image auditing method and system may be provided. Video surveillance equipment may be operated in coordination with at least one digital computer across network architecture. The video surveillance equipment may provide a computer with footage of a transactions occurring in a target area. The footage may be filtered into at least one image of a transaction. The image may be categorized based on at least one transaction characteristic. The transaction data may be compared to transaction records from a point of sale and analyzed for any discrepancies.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: ID proximity systems and methods for monitoring a movement of an object. A method comprises the steps of: using a second transponder to receive data transmitted by a first transponder attached to the object; and modifying the data based on at least one characteristic of the second transponder, wherein the second transponder is situated within a predetermined distance from the first transponder. The second transponder modifies the data by adding an identifier that corresponds to an operator. The second transponder may be worn by the operator.

Abstract: A system and method for monitoring beverage dispensing from a container. Independently obtained data from a pour event and ring up are matched using a recipe database. The method involves receiving ring up data for a transaction of the beverage dispensing, determining one or more beverage brands from a selected drink recipe using the ring up data and matching the ring up data with at least one of a plurality of pour event data entries using the determined one or more beverage brands, wherein each of the plurality of pour event data entries is obtained independently of the ring up data.

Abstract: The present invention provides systems and methods for monitoring the dispensing of a beverage from a dispensing apparatus into a container using a scale and other devices. Methods of the present invention may perform the following steps: measuring a scale time for the container on a scale, measuring a end weight for the container on the scale, and determining that a dispense event has occurred for the beverage based on whether a tilt condition of a dispensing apparatus occurred substantially within the scale time and based on whether the end weight of the beverage dispensed into the container approximates a serving based on point-of-sale information. In some embodiments the tilt condition is measured by a sensor device that does not contact the beverage being dispensed. Further embodiments may use pour time and the weight of the dispensing apparatus. The determined dispense event may determine the brand of the beverage dispensed.

Abstract: A system and method for monitoring beverage dispensing from a container. Independently obtained data from a pour event and ring up are matched using a recipe database. The method involves receiving ring up data for a transaction of the beverage dispensing, determining one or more beverage brands from a selected drink recipe using the ring up data and matching the ring up data with at least one of a plurality of pour event data entries using the determined one or more beverage brands, wherein each of the plurality of pour event data entries is obtained independently of the ring up data.